We are identifying and utilizing new ways to address cancer at its core. Using our expertise in epigenetics and drug development, we are creating novel therapeutics to correct the abnormal patterns of histone modifications seen in various cancers.follow the science
Innovators in Our Field
Tachyon operates with a dedicated internal core development team and a virtual external network of expertise to achieve one goal – advance our program with speed and innovation, without compromising the quality or integrity of our science.Meet the tachyon team
Tachyon completed seed funding and established fully operational organization.
Tachyon founded by scientific inventors to advance KDM4 program for clinical development.